Form 4 for HCA HCA Healthcare
Accepted 2025-11-04 00:00:00 ET · period of report 2025-10-31 · accession 0001193125-25-265148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-04 | 2025-10-31 | HCA | HAZEN SAMUEL N | CEO, Dir | F - Tax | $459.68 | -28.2K | 47.1K | -37% | -$12.95M |
| D | 2025-11-04 | 2025-10-31 | HCA | HAZEN SAMUEL N | CEO, Dir | M - OptEx | $69.58 | +58.0K | 75.3K | +337% | +$4.04M |
| D | 2025-11-04 | 2025-10-31 | HCA | HAZEN SAMUEL N | CEO, Dir | M - OptEx | $0.00 | -58.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-31 | F | D | 28,173 | $459.68 | 47,106 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-31 | M | A | 58,050 | $69.58 | 75,279 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2025-10-31 | M | D | 58,050 | $0.00 | 0 | D | $69.58 · — to 2026-01-29 | 58,050 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. |